Hepion Pharmaceuticals
HEPA
#10434
Rank
C$0.7 M
Marketcap
$0.65
Share price
-4.90%
Change (1 day)
-81.71%
Change (1 year)

Earnings for Hepion Pharmaceuticals (HEPA)

Earnings in 2024 (TTM): -C$40.52 Million

According to Hepion Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -C$70.21 Million a decrease over its 2022 earnings that were of -C$63.98 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hepion Pharmaceuticals from 2014 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$40.52 Million-42.28%
2023 -C$70.21 Million9.74%
2022 -C$63.98 Million37.49%
2021 -C$46.53 Million61.27%
2020 -C$28.86 Million174.55%
2019 -C$10.51 Million-31.28%
2018 -C$15.3 Million
2016 -C$30.36 Million6.03%
2015 -C$28.63 Million265%
2014 -C$7.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.21 Billion 375.25%๐Ÿ‡บ๐Ÿ‡ธ USA